Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter: Part 3. A potential 5-HT transporter imaging agent, 3-(3-[18F]Fluoropropyl)-6-nitroquipazine

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 23, 2003, Pages 4949-4958

  Lee, Byoung Se ^a   Chu, Soyoung ^a   Lee, Kyo Chul ^a   Lee, Bon Su ^a   Chi, Dae Yoon ^a   Choe, Yearn Seong ^b   Kim, Sang Eun ^b   Song, Yun Seon ^c   Jin, Changbae ^c  

^a Inha University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 CHLOROPROPYL) 6 NITRO 2 (PIPERAZIN 1 YL)QUINOLINE; 3 (3 FLUOROPROPYL) 6 NITRO 2 (PIPERAZIN 1 YL)QUINOLINE; 3 (3 FLUOROPROPYL) 6 NITROQUIPAZINE F 18; 3 BROMO 6 NITROQUIPAZINE; 3 ETHYL 6 NITRO 2 (PIPERAZIN 1 YL)QUINOLINE; 3 METHYL 6 NITRO 2 (PIPERAZIN 1 YL)QUINOLINE; 3 PROPYL 6 NITRO 2 (PIPERAZIN 1 YL)QUINOLINE; 6 NITROQUIPAZINE; CARBOSTYRIL DERIVATIVE; FLUORINE 18; FLUOXETINE; HYDROCARBOSTYRIL; MESYLIC ACID DERIVATIVE; MESYLIC ACID PROPYL ESTER; PAROXETINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; TETRABUTYLAMMONIUM; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; DRUG UPTAKE; FRONTAL CORTEX; ISOTOPE LABELING; MOUSE; NONHUMAN; PRECURSOR; RADIORECEPTOR ASSAY; RAT; TISSUE DISTRIBUTION;

EID: 0242298240     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.09.009     Document Type: Article

References (35)

1. Lee B.S., Chu S., Lee B.-S., Chi D.Y., Song Y.S., Jin C. Bioorg. Med. Chem. Lett. 12:2002;811.
2. Kung H.F. Nurotransmissions. 9(4):1993;1.
3. Frost J.J., Rosier A.J., Reich S.G., Smith J.S., Ehlers M.D., Snyder S.H., Ravert H.T., Dannals R.F. Ann. Neurol. 34:1993;423.
4. Wong D.F., Yung B., Dannals R.F., Shaya E.K., Ravert H.T., Chen C.A., Chan B., Folio T., Scheffel U., Ricaurte G.A., Neumeyer J.L., Wagner H.N. Jr., Kuhar M.J. Synapse. 15:1993;130.
5. Meltzer P.C., Liang A.Y., Brownell A.-L., Elmaleh D.R., Madras B.K. J. Med. Chem. 36:1993;855.
6. Innis R.B., Seibyl J.P., Scanley B.E., Laruelle M., Abi-Dargham A., Wallace E., Baldwin R.M., Zea-Ponce Y., Zoghbi S., Wang S., Gao Y., Neumeyer J.L., Charney D.S., Hoffer P.B., Marek K.L. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11965.
7. Seibyl J.P., Laruelle M.A., Van Dyck C.H., Wallace E., Baldwin R.M., Zoghbi S., Zea-Ponce Y., Neumeyer J.L., Charney D.S., Hoffer P.B., Innis R.B. J. Nucl. Med. 37:1996;222.
8. Kuikka J.T., Akerman K., Bergstrom K.A., Karhu J., Hiltunen J., Haukka J., Heikkinen J., Tiihonen J., Wang S., Neumeyer J.L. Eur, J. Nucl. Med. 22:1995;682.
9. Neumeyer J.L., Wang S.Y., Gao Y.G., Milius R.A., Kula N.S., Campbell A., Baldessarini R.J., Zea-Ponce Y., Baldwin R.M., Innis R.B. J. Med. Chem. 37:1994;1558.
10. Innis R.B. Eur. J. Nucl. Med. 21:1994;1.
11. Mozley P.D., Stubbs J.B., Kim H.-J., McElgin W., Kung M.-P., Meegalla S., Kung H.F. J. Nucl. Med. 37:1996;151.
12. Meegalla S.K., Plössl K., Kung M.-P., Chumpradit S., Stevenson D.A., Kushner S.A., McElgin W.T., Mozley P.D., Kung H.F. J. Med. Chem. 40:1997;9.
13. Meegalla S.K., Plössl K., Kung M.-P., Stevenson D.A., Mu M., Kushner S., Liable-Sands L.M., Rheingold A.L., Kung H.F. J. Med. Chem. 41:1998;428.
14. Choi S.R., Kung M.-P., Plössl K., Meegalla S., Kung H.F. Nucl. Med. Biol. 26:1999;461.
15. Kung M.-P., Stevenson D.A., Plössl K., Meegalla S.K., Beckwith A., Essman W.D., Mu M., Lucki I., Kung H.F. Eur. J. Nucl. Med. 24:1997;372.
16. Parsey R.V., Kegeles L.S., Hwang D.R., Simpson N., Abi-Dargham A., Mawlawi O., Slifstein M., Van Heertum R.L., Mann J.J., Laruelle M. J. Nucl. Med. 41:2000;1465.
17. Mathis C.A., Taylor S.E., Biegon A., Enas J.D. Brain Res. 619:1993;229.
18. Biegon A., Mathis C.A., Hanrahan S.M., Jagust W.J. Brain Res. 619:1993;236.
19. Mathis C.A., Enas J.D., Hanrahan S.M., Akgun E. J. Labelled Compd. Radiopharm. 34:1994;905.
20. Jagust W.J., Eberling J.L., Biegon A., Taylor S.E., VanBrocklin H.F., Jordan S., Hanrahan S.M., Roberts J.A., Brennan K.M., Mathis C.A. J. Nucl. Med. 37:1996;1207.
21. Lundkvist C., Loc'h C., Halldin C., Bottlaender M., Ottaviani M., Coulon C., Fuseau C., Mathis C., Farde L., Maziere B. Nucl. Med. Biol. 26:1999;501.
22. Acton P.D., Choi S.R., Hou C., Plossl K., Kung H.F. J. Nucl. Med. 42:2001;1556.
23. Acton P.D., Mu M., Plossl K., Hou C., Siciliano M., Zhuang Z.P., Oya S., Choi S.R., Kung H.F. Eur. J. Nucl. Med. 26:1999;1359.
24. Kung M.P., Hou C., Oya S., Mu M., Acton P.D., Kung H.F. Eur. J. Nucl. Med. 26:1999;844.
25. Hashimoto K., Goromaru T. Eur. J. Pharmacol. 180:1990;273.
26. Hashimoto K., Goromaru T. Neuropharmacology. 30:1991;113.
27. Hashimoto K., Goromaru T. Fundam. Clin. Pharmacol. 4:1990;635.
28. Hashimoto K., Goromaru T. Pharmacol. Exper. Ther. 255:1990;146.
29. Lee B.S., Chu S., Lee B.C., Chi D.Y., Choe Y.S., Jeong K.J., Jin C. Bioorg. Med. Chem. Lett. 10:2000;1559.
30. Lee B.S., Lee B.C., Jun J.G., Chi D.Y. Heterocycles. 48:1998;2637.
31. Miller G.M., Yatin S.M., De La Garza R. II, Goulet M., Madras B.K. Mol. Brain Res. 87:2001;124.
32. Pähkla R., Rägo L., Callaway J.J., Airaksinen M.M. Pharmacol. Toxicol. 80:1997;122.
33. Zukin S.R., Young A.B., Snyder S.H. Proc. Natl. Acad. Sci. U.S.A. 71:1974;4802.
34. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
35. Fowler J.S., Arnett C.D., Wolf A.P., MacGregor R.R., Norton E.F., Findley A.M. J. Nucl. Med. 23:1982;437.